Breaking News Instant updates and real-time market news.

JBL

Jabil Circuit

$29.00

-0.1 (-0.34%)

, MMP

Magellan Midstream

$68.33

0.395 (0.58%)

10:19
06/22/17
06/22
10:19
06/22/17
10:19

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Jabil Circuit (JBL) initiated with an Outperform at Macquarie. 2. Magellan Midstream (MMP) initiated with a Hold at Jefferies. 3. AvalonBay (AVB) initiated with a Buy at Argus. 4. Aqua Metals (AQMS) initiated with a Buy at Rodman & Renshaw. 5. Del Taco (TACO) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

JBL

Jabil Circuit

$29.00

-0.1 (-0.34%)

MMP

Magellan Midstream

$68.33

0.395 (0.58%)

AVB

AvalonBay

$193.47

-1.09 (-0.56%)

AQMS

Aqua Metals

$11.95

-0.36 (-2.92%)

TACO

Del Taco

$13.87

0.14 (1.02%)

JBL Jabil Circuit
$29.00

-0.1 (-0.34%)

06/22/17
MACQ
06/22/17
INITIATION
Target $32.5
MACQ
Outperform
Jabil Circuit initiated with an Outperform at Macquarie
Macquarie analyst Gus Papageorgiou initiated Jabil Circuit (JBL) with an Outperform and a $32.50 price target due to low valuation, Apple (AAPL), and the strongest earnings growth in the group.
03/20/17
ARGS
03/20/17
NO CHANGE
ARGS
Apple has positive read through from Jabil results, says Argus
Argus analyst Jim Kelleher believes that Jabil (JBL) reported "solid" results which bode well for Apple (AAPL). However, the analyst says that Jabil has been disappointing after triggering elevated expectations in the past, and he keeps a Hold rating on that stock.
06/15/17
UBSW
06/15/17
NO CHANGE
Target $35
UBSW
Buy
Jabil Circuit price target raised to $35 from $30 at UBS
UBS analyst Steven Milunovich raised his price target on Jabil Circuit (JBL) to $35 from $30 following solid Q3 results and its positive 2018 outlook. The analyst said the company still has a 24% revenue dependence on Apple (AAPL). Based on its guidance for 2018, it must have reasonable confidence in the iPhone 8 cycle, said Milunovich, who reiterated his Buy rating on Jabil shares.
06/15/17
COWN
06/15/17
NO CHANGE
Target $160
COWN
Outperform
Jabil Circuit results indicate no glaring issues for Apple, says Cowen
Cowen analyst Timothy Arcuri noted that Jabil Circuits' (JBL) results beat estimates and the company raised guidance. He said the read-through from the report indicate no glaring issues for the iPhone launch. His field work suggests Apple's (AAPL) June quarter is ok, but the September iPhone supply still appears roughly 3-4M below what is implied by the Street. Arcuri maintains his Outperform rating and $160 price target on Apple shares.
MMP Magellan Midstream
$68.33

0.395 (0.58%)

06/22/17
JEFF
06/22/17
INITIATION
Target $73
JEFF
Hold
Magellan Midstream initiated with a Hold at Jefferies
Jefferies analyst Christopher Sighinolfi started Magellan Midstream with a Hold rating, as he views its best-in-class leverage and robust distribution growth as fully reflected in its current valuation. He set a $73 price target on the shares.
05/04/17
FBCO
05/04/17
UPGRADE
Target $84
FBCO
Neutral
Magellan Midstream upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst John Edwards upgraded Magellan Midstream to Neutral and raised its price target to $84 from $80 citing a growing list of backlog projects.
04/21/17
MACQ
04/21/17
INITIATION
Target $80
MACQ
Neutral
Magellan Midstream initiated with a Neutral at Macquarie
Macquarie analyst Andrew Weisel initiated Magellan Midstream with a Neutral and an$80 price target due to the valuation premium.
03/06/17
SBSH
03/06/17
DOWNGRADE
Target $82
SBSH
Neutral
Magellan Midstream downgraded to Neutral from Buy at Citi
Citi analyst Faisel Khan downgraded Magellan Midstream Partners L.P to Neutral citing valuation. The analyst views the stock as fairly valued at current levels. He raised his price target for the shares to $82 from $73 saying Magellan's fundamentals remain strong.
AVB AvalonBay
$193.47

-1.09 (-0.56%)

06/22/17
ARGS
06/22/17
INITIATION
Target $220
ARGS
Buy
AvalonBay initiated with a Buy at Argus
Argus analyst Jacob Kilstein initiated AvalonBay with a a Buy and a $220 price target saying it has strong opportunities in the high-end apartment market which has high barriers to entry. The company's communities are located in leading metropolitan areas marked by rising employment, high wages and the appeal of city amenities and believes challenges of higher interest rates and oversupply are already priced into shares.
05/17/17
DBAB
05/17/17
DOWNGRADE
Target $193
DBAB
Hold
AvalonBay downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Vin Chao downgraded AvalonBay Communities to Hold citing valuation and his belief that consensus expectations are too high for the second half of 2017. The analyst sees continued supply growth in 2017 and into 2018 and keeps a $193 price target for the shares.
04/19/17
JMPS
04/19/17
DOWNGRADE
JMPS
Market Perform
AvalonBay downgraded to Market Perform from Outperform at JMP Securities
04/19/17
JMPS
04/19/17
DOWNGRADE
JMPS
Market Perform
AvalonBay downgraded on valuation, asset outlook at JMP Securities
As noted earlier, JMP Securities downgraded AvalonBay to Market Perform from Outperform. Analyst Aaron Hecht downgraded the stock based on "valuation and asset level performance/risk." .He adds that the residential REIT space lacks catalysts due to "mixed" macro data and reduced potential for legislation that could boost the economy.
AQMS Aqua Metals
$11.95

-0.36 (-2.92%)

06/22/17
RODM
06/22/17
INITIATION
Target $25
RODM
Aqua Metals initiated with a Buy at Rodman & Renshaw
Rodman & Renshaw analyst Amit Dayal initiated Aqua Metals (AQMS) with a Buy and a $25 saying strategic alliances with Johnson Controls (JCI), Interstate Batteries, and Battery Systems validates the company's technology and provides visibility into revenues.
03/13/17
OPCO
03/13/17
NO CHANGE
Target $34
OPCO
Outperform
Aqua Metals price target raised to $34 from $16 at Oppenheimer
Oppenheimer analyst Colin Rusch raised his price target for Aqua Metals (AQMS) to $34 from $16 after the company's recent filings and in light of its strategic agreement with Johnson Controls (JCI). The analyst continues to believe this agreement is transformative for Aqua Metals as it provides the company with stable, clearly priced demand for five years, and provides a key licensee for its technology and a partner for using the value-added product of its AquaRefining process. He reiterates an Outperform rating on Aqua Metals' shares.
02/16/17
NATB
02/16/17
INITIATION
Target $26
NATB
Outperform
Aqua Metals initiated with an Outperform at National Bank
National Bank initiated Aqua Metals with an Outperform and a $26 price target.
06/01/17
OPCO
06/01/17
NO CHANGE
Target $34
OPCO
Outperform
Oppenheimer constructive on Aqua Metals after facility visit
Oppenheimer analyst Colin Rusch says his visit to Aqua Metals' Reno facility suggests the company is tracking well the cost numbers management has guided to, which he views as the biggest issue for the shares. The analyst sees a "significant amount of additional margin" for higher purity lead and believes mix could drive upside to his expectations. Rusch remains "constructive" on the shares with an Outperform rating and $34 price target.
TACO Del Taco
$13.87

0.14 (1.02%)

11/25/16
PIPR
11/25/16
NO CHANGE
PIPR
Piper thinks blocking of Overtime Rule came too late
An Obama-appointed judge in Texas surprisingly blocked the Overtime Rule set to take effect on December 1, Piper Jaffray analysts in the Hardlines Retail & Specialty Products space tell investors in a research note. The analysts say that regardless of whether the injunction is upheld, their research suggests that the ruling comes too late for larger companies to pull back on the planned Overtime Rule change. Payroll and IT systems are likely set to adjust this coming Sunday, they point out. Piper's analysts expect the expense headwinds from the OT rule change for retailers/restaurants to remain in place. The retailers they believe that are most impacted from the rule are Dollar General (DG), Dollar Tree (DLTR), Regis (RGS) and Sally Beauty (SBH). The restaurants they believe are most impacted are Bojangles (BOJA), Starbucks (SBUX), Sonic (SONC), Noodles & Company (NDLS), Potbelly (PBPB), Del Taco (TACO) and Zoe's Kitchen (ZOES).
03/14/17
WEDB
03/14/17
NO CHANGE
WEDB
Del Taco Q1 comps were "well above expectations," says Wedbush
Wedbush analyst Nick Setyan says that Del Taco's Q1 comp sales were "well above expectations given weather, tax refunds and other headwinds." He adds that the company's 2017 comp guidance was "strong," and he expects the stock's valuation to rise. The analyst keeps a $17 price target and an Outperform rating on the shares.
06/22/17
MAXM
06/22/17
INITIATION
Target $19
MAXM
Buy
Del Taco initiated with a Buy at Maxim
Maxim analyst Stephen Anderson started Del Taco with a Buy rating and $19 price target, calling accelerated new unit growth its most important top-line driver and saying he thinks labor costs will moderate slightly through 2018.

TODAY'S FREE FLY STORIES

CME

CME Group

$154.28

2.07 (1.36%)

, GS

Goldman Sachs

$256.12

5.15 (2.05%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Bar Association to hold annual meeting »

Derivatives & Futures…

CME

CME Group

$154.28

2.07 (1.36%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BP

BP

$42.40

-0.5 (-1.17%)

C

Citi

$78.30

0.91 (1.18%)

BAC

Bank of America

$31.72

0.24 (0.76%)

CS

Credit Suisse

$19.06

0.13 (0.69%)

CRL

Charles River

$107.89

1.22 (1.14%)

MS

Morgan Stanley

$57.46

1.62 (2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

AMGN

Amgen

$189.28

1.69 (0.90%)

, BAYRY

Bayer

$32.05

0.235 (0.74%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2018 ASCO…

AMGN

Amgen

$189.28

1.69 (0.90%)

BAYRY

Bayer

$32.05

0.235 (0.74%)

BLRX

BioLineRx

$1.09

-0.02 (-1.80%)

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

CELG

Celgene

$102.65

0.93 (0.91%)

DNA

Bought by RHHBY

ESALY

Eisai

$56.88

0.115 (0.20%)

EXEL

Exelixis

$28.00

0.14 (0.50%)

HALO

Halozyme

$17.98

0.13 (0.73%)

INCY

Incyte

$93.16

1.24 (1.35%)

IPSEY

Ipsen

$34.65

0.75 (2.21%)

LXRX

Lexicon

$10.44

0.2 (1.95%)

MGNX

MacroGenics

$19.19

0.3 (1.59%)

MRK

Merck

$61.28

0.15 (0.25%)

NVS

Novartis

$86.94

0.53 (0.61%)

SNY

Sanofi

$44.60

0.09 (0.20%)

ONCY

Oncolytics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 02

    Feb

  • 03

    Feb

  • 05

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 02

    Mar

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

  • 23

    Oct

WLFC

Willis Lease

$26.66

0.05 (0.19%)

18:59
01/19/18
01/19
18:59
01/19/18
18:59
Hot Stocks
Willis Lease announces $1,000 bonus for employees »

Willis Lease announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary at MUFG »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

GRPN

Groupon

$5.57

0.46 (9.00%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Hot Stocks
Groupon announces Chief Product Officer Jay Sullivan resigns »

On January 17, Jay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41
Hot Stocks
Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial »

Celgene announced primary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

VALU

Value Line

$19.60

0.3 (1.55%)

17:40
01/19/18
01/19
17:40
01/19/18
17:40
Hot Stocks
Value Line reaffirms $3M stock repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALU

Value Line

$19.60

0.3 (1.55%)

17:39
01/19/18
01/19
17:39
01/19/18
17:39
Hot Stocks
Value Line declares special dividend of 20c per share »

Payable on March 9 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEAL

Zealand Pharma

$15.05

-0.78 (-4.93%)

17:34
01/19/18
01/19
17:34
01/19/18
17:34
Hot Stocks
Zealand Pharma: FDA approves IND for Phase 3 trials of dasiglucagon in CHI »

The U.S. FDA has approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

HII

Huntington Ingalls

$242.12

5.24 (2.21%)

17:21
01/19/18
01/19
17:21
01/19/18
17:21
Hot Stocks
Huntington Ingalls awarded $125.2M government contract modification »

Huntington Ingalls Inc. -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 21

    Feb

BAESY

BAE Systems

$33.30

0.18 (0.54%)

, GD

General Dynamics

$209.10

1.3 (0.63%)

17:20
01/19/18
01/19
17:20
01/19/18
17:20
Hot Stocks
BAE Systems, General Dynamics awarded $237.6M government contract modification »

BAE Systems (BAESY) San…

BAESY

BAE Systems

$33.30

0.18 (0.54%)

GD

General Dynamics

$209.10

1.3 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SYRS

Syros Pharmaceuticals

$10.80

0.27 (2.56%)

17:17
01/19/18
01/19
17:17
01/19/18
17:17
Syndicate
Breaking Syndicate news story on Syros Pharmaceuticals »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTFC

Wintrust Financial

$87.81

0.96 (1.11%)

17:13
01/19/18
01/19
17:13
01/19/18
17:13
Hot Stocks
Wintrust Financial raises its minimum wage to $15 per hour »

Wintrust Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

TWTR

Twitter

$23.66

-0.38 (-1.58%)

17:07
01/19/18
01/19
17:07
01/19/18
17:07
Hot Stocks
Twitter says has identified more IRA and automated Russia-based accounts »

In a statement on its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

ITEK

Inotek Pharmaceuticals

17:04
01/19/18
01/19
17:04
01/19/18
17:04
Hot Stocks
Boxer Capital reports 5.3% passive stake in Rocket Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OIS

Oil States

$32.80

0.35 (1.08%)

17:03
01/19/18
01/19
17:03
01/19/18
17:03
Syndicate
Breaking Syndicate news story on Oil States »

Oil States files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$266.39

-3.41 (-1.26%)

, QCOM

Qualcomm

$68.04

-0.01 (-0.01%)

16:43
01/19/18
01/19
16:43
01/19/18
16:43
Hot Stocks
Broadcom receives second request from FTC for proposed Qualcomm deal »

Broadcom (AVGO) announced…

AVGO

Broadcom

$266.39

-3.41 (-1.26%)

QCOM

Qualcomm

$68.04

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

TRNC

tronc

$19.53

0.3 (1.56%)

16:37
01/19/18
01/19
16:37
01/19/18
16:37
Periodicals
LA Times' CEO Ross Levinsohn to take leave of absence amid probe, WSJ says »

Ross Levinsohn, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AP

Ampco-Pittsburgh

$14.20

0.15 (1.07%)

16:35
01/19/18
01/19
16:35
01/19/18
16:35
Syndicate
Breaking Syndicate news story on Ampco-Pittsburgh »

Ampco-Pittsburgh files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

CG

Carlyle Group

$24.35

-0.05 (-0.20%)

, UBSH

Union Bankshares

$38.79

0.54 (1.41%)

16:33
01/19/18
01/19
16:33
01/19/18
16:33
Hot Stocks
Carlyle Group reports 6% passive stake in Union Bankshares »

In a regulatory filing,…

CG

Carlyle Group

$24.35

-0.05 (-0.20%)

UBSH

Union Bankshares

$38.79

0.54 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ANDX

Andeavor Logistics

$52.52

0.12 (0.23%)

16:31
01/19/18
01/19
16:31
01/19/18
16:31
Hot Stocks
Andeavor Logistics raises quarterly cash distribution to $1.00 per unit »

The fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.